These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11176589)

  • 1. Efficacy of ofloxacin and other ototopical preparations for chronic suppurative otitis media in children.
    Bluestone CD
    Pediatr Infect Dis J; 2001 Jan; 20(1):111-5; discussion 120-2. PubMed ID: 11176589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ofloxacin and other otic preparations for acute otitis media in patients with tympanostomy tubes.
    Goldblatt EL
    Pediatr Infect Dis J; 2001 Jan; 20(1):116-9; discussion 120-2. PubMed ID: 11176590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents.
    Klein JO
    Pediatr Infect Dis J; 2001 Jan; 20(1):102-3; discussion 120-2. PubMed ID: 11176586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of topical ofloxacin for otic diseases in infants and children. Summary and conclusions.
    Klein JO; McCracken GH
    Pediatr Infect Dis J; 2001 Jan; 20(1):123-5. PubMed ID: 11176592
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of chronic suppurative otitis media with ofloxacin in hydroxypropyl methylcellulose ear drops: a clinical/bacteriological study in a rural area of Malawi.
    van Hasselt P; van Kregten E
    Int J Pediatr Otorhinolaryngol; 2002 Mar; 63(1):49-56. PubMed ID: 11879929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriology of chronic suppurative otitis media: ofloxacin susceptibility.
    Yuen AP; Chau PY; Wei WI
    J Otolaryngol; 1995 Jun; 24(3):206-8. PubMed ID: 7674449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial of ototopical ofloxacin for treatment of chronic suppurative otitis media.
    Agro AS; Garner ET; Wright JW; Caballeros de Escobar I; Villeda B; Seidlin M
    Clin Ther; 1998; 20(4):744-59. PubMed ID: 9737834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of ofloxacin and other otic preparations for otitis externa.
    Ruben RJ
    Pediatr Infect Dis J; 2001 Jan; 20(1):108-10; discussion 120-2. PubMed ID: 11176588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical ofloxacin for chronic suppurative otitis media and acute exacerbation of chronic otitis media: optimum duration of treatment.
    Suzuki K; Nishimura T; Baba S; Yanagita N; Ishigami H
    Otol Neurotol; 2003 May; 24(3):447-52. PubMed ID: 12806297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of the effectiveness of ofloxaxin otic solution for the treatment of suppurative otitis media.
    Abes G; Espallardo N; Tong M; Subramaniam KN; Hermani B; Lasiminigrum L; Anggraeni R
    ORL J Otorhinolaryngol Relat Spec; 2003; 65(2):106-16. PubMed ID: 12824733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ofloxacin otic solution as treatment of chronic suppurative otitis media and diffuse bacterial otitis externa.
    Sumitsawan Y; Tharavichitkul P; Prawatmuang W; Ingsuwan B; Sriburi P
    J Med Assoc Thai; 1995 Sep; 78(9):455-9. PubMed ID: 7561571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical ofloxacin versus systemic amoxicillin/clavulanate in purulent otorrhea in children with tympanostomy tubes.
    Goldblatt EL; Dohar J; Nozza RJ; Nielsen RW; Goldberg T; Sidman JD; Seidlin M
    Int J Pediatr Otorhinolaryngol; 1998 Nov; 46(1-2):91-101. PubMed ID: 10190709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of chronic suppurative otitis media and otitis externa with 0.3 per cent ofloxacin otic solution: a clinico-microbiological study.
    Supiyaphun P; Tonsakulrungruang K; Chochaipanichnon L; Chongtateong A; Samart Y
    J Med Assoc Thai; 1995 Jan; 78(1):18-21. PubMed ID: 7622972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacteriological profile in chronic suppurative otitis media in Eastern Nepal.
    Sharma S; Rehan HS; Goyal A; Jha AK; Upadhyaya S; Mishra SC
    Trop Doct; 2004 Apr; 34(2):102-4. PubMed ID: 15117142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ofloxacin eardrop treatment for active chronic suppurative otitis media: prospective randomized study.
    Yuen PW; Lau SK; Chau PY; Hui Y; Wong SF; Wong S; Wei WI
    Am J Otol; 1994 Sep; 15(5):670-3. PubMed ID: 8572070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ofloxacin otic solution: a review of its use in the management of ear infections.
    Simpson KL; Markham A
    Drugs; 1999 Sep; 58(3):509-31. PubMed ID: 10493278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of ofloxacin otic and other ototopical treatments in animal models and in humans.
    Gates GA
    Pediatr Infect Dis J; 2001 Jan; 20(1):104-7; discussion 120-2. PubMed ID: 11176587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ofloxacin otic solution in patients with otitis media: an analysis of drug concentrations.
    Ohyama M; Furuta S; Ueno K; Katsuda K; Nobori T; Kiyota R; Miyazaki Y
    Arch Otolaryngol Head Neck Surg; 1999 Mar; 125(3):337-40. PubMed ID: 10190808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of ofloxacin and its combination with dexamethasone in chronic suppurative otitis media. A randomised, double blind, parallel group, comparative study.
    Panchasara A; Singh A; Mandavia D; Jha S; Tripathi C
    Acta Otorhinolaryngol Ital; 2015 Feb; 35(1):39-44. PubMed ID: 26015650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparative study of ofloxacin otic drops versus neomycin-polymyxin B-hydrocortisone otic drops in the medical treatment of chronic suppurative otitis media.
    Tong MC; Woo JK; van Hasselt CA
    J Laryngol Otol; 1996 Apr; 110(4):309-14. PubMed ID: 8733449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.